Michael Brooks

Chief Development Officer, Clinical
  • Leads the global Clinical Development organization encompassing clinical pharmacology services, full service clinical trial and product development capabilities, scientific and therapeutic expertise, FSP and hybrid models, and digital and mobile health solutions
  • Responsible for ensuring a product development mindset throughout the organization; Focused on maximizing the return on investments for customers, providing an exceptional customer experience and achieving growth targets; Implements innovative solutions through integrated Syneos Health commercial capabilities, patient and healthcare professional insights and digital engagement
  • 25+ years of clinical development and commercialization experience; strong track record of transforming business units and companies, setting strategy and spearheading high-value solutions across the product development lifecycle
  • Brings extensive global product development experience to Syneos Health from prior roles, including serving as President & Global Head at LabCorp (Covance) Clinical Development & Commercialization Services and Executive Vice President & Global Head of Clinical Development at PRA Health Sciences encompassing work across phase I-IV, FSP, clinical pharmacology/phase I units, real-world outcomes/post marketing, consulting, commercial services and global service delivery hubs in China and India
  • Bachelor of Science, North Carolina State University; Member, College of Sciences Foundation Board of Directors, North Carolina State University